Jump to ContentJump to Main Navigation
Innovation in Local EconomiesGermany in Comparative Context$
Users without a subscription are not able to see the full content.

Colin Crouch and Helmut Voelzkow

Print publication date: 2009

Print ISBN-13: 9780199551170

Published to Oxford Scholarship Online: May 2009

DOI: 10.1093/acprof:oso/9780199551170.001.0001

Show Summary Details
Page of

PRINTED FROM OXFORD SCHOLARSHIP ONLINE (www.oxfordscholarship.com). (c) Copyright Oxford University Press, 2018. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a monograph in OSO for personal use (for details see http://www.oxfordscholarship.com/page/privacy-policy).date: 20 July 2018

The Development of Munich and Cambridge Therapeutic Biotech Firms: A Case Study of Institutional Adaptation

The Development of Munich and Cambridge Therapeutic Biotech Firms: A Case Study of Institutional Adaptation

Chapter:
(p.121) 6 The Development of Munich and Cambridge Therapeutic Biotech Firms: A Case Study of Institutional Adaptation
Source:
Innovation in Local Economies
Author(s):

Simcha Jong

Publisher:
Oxford University Press
DOI:10.1093/acprof:oso/9780199551170.003.0006

In order to understand better the development of the therapeutic biotech firms in the Munich region, Germany's largest and most successful biotech cluster, this chapter contrasts the development of Munich firms with that in the Cambridge region in the UK. The chapter proceeds as follows. First, it discusses how the comparative case study will increase the understanding of the mechanisms through which entrepreneurs in a new industry are able to overcome pre-existing institutional barriers to their firms' development. Second, it outlines the main organizational challenges with which biotech entrepreneurs in Cambridge and Munich have been confronted in building up a biotech firm. Third, it analyzes how Munich's and Cambridge's therapeutic biotech firms have relied on their institutional environments differently to develop their firms' capabilities to deal with these organizational challenges. Fourth, it discusses how the different institutional paths which Cambridge's and Munich's biotech entrepreneurs have followed to deal with key organizational challenges have affected the development of these firms. Finally, the main findings are summarized and some implications of this study for broader debates in the comparative institutional literature are suggested.

Keywords:   biotechnology, Munich, Cambridge, inter-company relations, entrepreneurs, institutional environments

Oxford Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.

Please, subscribe or login to access full text content.

If you think you should have access to this title, please contact your librarian.

To troubleshoot, please check our FAQs , and if you can't find the answer there, please contact us .